Télécharger le supplément (250 p.) - KCE

More documents

Recommendations

Info

130 Médecine à l'acte / médecine au forfait - ANNEXES KCE Reports 85 S Parameter Estimate Standard Error t Value Pr > |t| age*PP0020 1-4 ans 1 -52.6874821 B 94.4218739 -0.56 0.5768 age*PP0020 1-4 ans 2 0.0000000 B . . . age*PP0020 25-39 ans 1 -151.8347525 B 90.2651229 -1.68 0.0926 age*PP0020 25-39 ans 2 0.0000000 B . . . age*PP0020 40-64 ans 1 -132.2625646 B 90.1624803 -1.47 0.1424 age*PP0020 40-64 ans 2 0.0000000 B . . . age*PP0020 5-24 ans 1 -74.9045263 B 90.0699349 -0.83 0.4056 age*PP0020 5-24 ans 2 0.0000000 B . . . age*PP0020 65-74 ans 1 -78.0526016 B 92.0056512 -0.85 0.3963 age*PP0020 65-74 ans 2 0.0000000 B . . . age*PP0020 75-84 ans 1 -45.6843184 B 94.5218043 -0.48 0.6289 age*PP0020 75-84 ans 2 0.0000000 B . . . age*PP0020 85-+ ans 1 0.0000000 B . . . age*PP0020 85-+ ans 2 0.0000000 B . . . age*VPO 1-4 ans 1 191.5587335 B 274.9692560 0.70 0.4860 age*VPO 1-4 ans 2 0.0000000 B . . . age*VPO 25-39 ans 1 165.0117925 B 208.2419884 0.79 0.4281 age*VPO 25-39 ans 2 0.0000000 B . . . age*VPO 40-64 ans 1 306.2139610 B 196.9408220 1.55 0.1200 age*VPO 40-64 ans 2 0.0000000 B . . . age*VPO 5-24 ans 1 213.0534877 B 197.9443910 1.08 0.2818 age*VPO 5-24 ans 2 0.0000000 B . . . age*VPO 65-74 ans 1 252.8201889 B 202.2237474 1.25 0.2112 age*VPO 65-74 ans 2 0.0000000 B . . . age*VPO 75-84 ans 1 312.5532431 B 218.8545238 1.43 0.1533 age*VPO 75-84 ans 2 0.0000000 B . . . age*VPO 85-+ ans 1 0.0000000 B . . . age*VPO 85-+ ans 2 0.0000000 B . . . The X'X matrix has been found to be singular, and a generalized inverse was used to solve the normal equations. Terms whose estimates are followed by the letter 'B' are not uniquely estimable. Standardisation Cohorte 2 - 2e ligne médecine spécialisée cat101predit Mean 219.37 GLM MULTIVARIÉ – OFFICINES Essai 1 - en mettant toutes les intéractions possibles Class Level Information Class Levels Values age 7 1-4 ans 25-39 ans 40-64 ans 5-24 ans 65-74 ans 75-84 ans 85-+ ans im 2 1 2 inv 2 1 2 PP0020 2 1 2 prep 2 1 2 VPO 2 1 2 chom3 2 1 2 aidsoc 2 1 2 Number of Observations Read 21778 Number of Observations Used 21778
KCE Reports 85 S Médecine à l'acte : médecine au forfait - ANNEXES 131 Source DF Sum of Squares Mean Square F Value Pr > F Model 63 2840740229.9 45091114.76 5.67 F age 6 738831546.0 123138591.0 15.47
Page 1 and 2:
Comparaison du coût et de la quali
Page 3 and 4:
Comparaison du coût et de la quali
Page 5 and 6:
KCE Reports 85 S Médecine à l’a
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84: KCE Reports 85 S Médecine à l’a
Page 113 and 114: KCE Reports 85 S Médecine à l'act
Page 133: KCE Reports 85 S Médecine à l'act
Page 185 and 186:
KCE Reports 85 S Médecine à l'act
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
This page is left intentionally bla
Page 247 and 248:
KCE reports 1. Efficacité et renta
Page 249:
74. Oxygénothérapie Hyperbare: Ra
show all

Télécharger le supplément (250 p.) - KCE

Create successful ePaper yourself

Delete template?

Save as template?